These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Study of the effect of nitroglycerin on the hemodynamics and contractile function of6the myocardium using electrokymography]. Kuznetsova VP Kardiologiia; 1969 Dec; 9(12):104-7. PubMed ID: 4986574 [No Abstract] [Full Text] [Related]
27. [Changes in the level and composition of blood lipoproteins in ischemic heart disease with intact coronary arteries]. Gasilin VS; Kurdanov KhA; Perova NV; Torkhovskaia TI; Shcherbakova IA Ter Arkh; 1980; 52(5):14-8. PubMed ID: 7404358 [No Abstract] [Full Text] [Related]
28. Clofibrate and androsterone effect on serum lipids. Orgain ES; Bogdonoff MD; Cain C Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838 [No Abstract] [Full Text] [Related]
29. [Lipid metabolism in patients with chronic renal insufficiency under conservative treatment (author's transl)]. Schäfer B; Kluthe R Med Klin; 1974 Apr; 69(14):577-81. PubMed ID: 4838935 [No Abstract] [Full Text] [Related]
30. [Effect of alpha-methyldopa (dopegit) on some blood circulation indices]. Glezer GA; Pushkar' IuT; Spibak GL; Moskalenko NP; Aranas'eva LS; Soboleva VA Sov Med; 1969 Feb; 32(2):21-6. PubMed ID: 5380419 [No Abstract] [Full Text] [Related]
31. [Clinical-experimental studies on lipid metabolism using Regelan]. Hammerl H Wien Klin Wochenschr; 1967 Sep; 79(39):720-2. PubMed ID: 4875575 [No Abstract] [Full Text] [Related]
32. [Clinical evaluation of the therapeutic activity of the -pyridyl-carbinol ester of clofibric acid]. Silingardi V; Renzi R; Mora A; Di Prisco AU Minerva Med; 1973 Mar; 64(16):751-69. PubMed ID: 4704721 [No Abstract] [Full Text] [Related]
33. [Comparative study of blood lipids in coronary sclerosis and cerebrosclerosis]. Keller L; Fischer J; Farádi A Orv Hetil; 1974 Jun; 115(23):1323-7. PubMed ID: 4840692 [No Abstract] [Full Text] [Related]
34. [Several problems of the biochemical characteristics of various stages of coronary arteriosclerosis]. Rachinskiĭ ID Kardiologiia; 1967 Mar; 7(3):123-5. PubMed ID: 4973895 [No Abstract] [Full Text] [Related]
35. [Hemodynamic changes following blockade of the beta-receptors in healthy persons and in patients with coronary heart disease. Comparison between Trasicor and Inderal]. Bürgin D Schweiz Med Wochenschr; 1968 Jun; 98(25):940-5. PubMed ID: 5699197 [No Abstract] [Full Text] [Related]
36. [Triglycerides and other blood lipids in patients with coronary atherosclerosis]. Baranova LV Kardiologiia; 1968 Apr; 8(4):31-4. PubMed ID: 5660747 [No Abstract] [Full Text] [Related]
37. [Dyslipidemia as a risk factor in atherogenesis]. Panaitescu G; Fica V; Stănescu L; Serban M; Roşca L; Enache M Med Interna (Bucur); 1972 Apr; 24(4):423-40. PubMed ID: 5027788 [No Abstract] [Full Text] [Related]
38. [Evaluation of the effectiveness of the treatment of arteriosclerosis]. Bobkova VI; Mazurova SV; Fomchenkov SI Kardiologiia; 1974 Jul; 14(7):108-13. PubMed ID: 4431129 [No Abstract] [Full Text] [Related]
39. Treatment of hypercholesterolaemia with colestipol: a bile sequestrating agent. Nye ER; Jackson D; Hunter JD N Z Med J; 1972 Jul; 76(482):12-6. PubMed ID: 4344110 [No Abstract] [Full Text] [Related]